For: | Chen QF, Li W, Wu PH, Shen LJ, Huang ZL. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2019; 25(35): 5266-5282 [PMID: 31558872 DOI: 10.3748/wjg.v25.i35.5266] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i35/5266.htm |
Number | Citing Articles |
1 |
Haitao Chen, Yueying Li, Shu-Yuan Xiao, Jianchun Guo. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08012-2
|
2 |
Jianbo Ning, Yutao Wang, Zijia Tao. The complex role of immune cells in antigen presentation and regulation of T-cell responses in hepatocellular carcinoma: progress, challenges, and future directions. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1483834
|
3 |
Kaifei Zhao, Lin Xu, Feng Li, Jin Ao, Guojun Jiang, Rongshu Shi, Fang Chen, Qing Luo. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature. Bioscience Reports 2020; 40(8) doi: 10.1042/BSR20200894
|
4 |
Meiying Long, Zihan Zhou, Xueyan Wei, Qiuling Lin, Moqin Qiu, Yunxiang Zhou, Peiqin Chen, Yanji Jiang, Qiuping Wen, Yingchun Liu, Runwei Li, Xianguo Zhou, Hongping Yu. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1023349
|
5 |
Yu Jiang, Lijuan Lin, Huiming Lv, He Zhang, Lili Jiang, Fenfen Ma, Qiuyue Wang, Xue Ma, Shengjin Yu. Immune cell infiltration and immunotherapy in hepatocellular carcinoma. Mathematical Biosciences and Engineering 2022; 19(7): 7178 doi: 10.3934/mbe.2022339
|
6 |
Lixing Li, Lu Shen, Jingsong Ma, Qiang Zhou, Mo Li, Hao Wu, Muyun Wei, Di Zhang, Ting Wang, Shengying Qin, Tonghai Xing. Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00451
|
7 |
Jianguo Li, Jin Zhou, Shuangshuang Kai, Can Wang, Daijun Wang, Jiying Jiang. Functional and Clinical Characterization of Tumor-Infiltrating T Cell Subpopulations in Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.586415
|
8 |
Bo Hu, Xiao-Bo Yang, Xin-Ting Sang. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients. International Immunopharmacology 2021; 90: 107164 doi: 10.1016/j.intimp.2020.107164
|
9 |
Jun Liu, Zheng Chen, Wenli Li, Zhixiong Liu. Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/6676537
|
10 |
Banglun Pan, Lin Liu, Wei Li. A prognostic risk model based on immune‐related genes predicts overall survival of patients with hepatocellular carcinoma. Health Science Reports 2020; 3(4) doi: 10.1002/hsr2.202
|
11 |
Rongfu Huang, Zheng Chen, Wenli Li, Chunmei Fan, Jun Liu. Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma. International Journal of Oncology 2020; doi: 10.3892/ijo.2020.4998
|
12 |
Yue Ding, Yilin Yan, Yihui Dong, Jingyuan Xu, Wei Su, Weijun Shi, Qi Zou, Xiaoping Yang. NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis. International Immunopharmacology 2022; 104: 108512 doi: 10.1016/j.intimp.2021.108512
|
13 |
Leteng Yang, Jie Wei, Xiaoya Ma, Rui Cheng, Huan Zhang, Tianbo Jin. Pan-Cancer Analysis of the Prognostic and Immunological Role of <i>SMG5</i>: A Biomarker for Cancers. Oncology 2024; 102(2): 168 doi: 10.1159/000533421
|
14 |
Jian-Nan Liu, Xiang-Shuo Kong, Tao Huang, Rui Wang, Wang Li, Qi-Feng Chen. Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.02048
|
15 |
Dao-Han Zhang, Chen Liang, Shu-Yang Hu, Xiao-Yong Huang, Lei Yu, Xian-Long Meng, Xiao-Jun Guo, Hai-Ying Zeng, Zhen Chen, Lv Zhang, Yan-Zi Pei, Mu Ye, Jia-Bin Cai, Pei-Xin Huang, Ying-Hong Shi, Ai-Wu Ke, Yi Chen, Yuan Ji, Yujiang Geno Shi, Jian Zhou, Jia Fan, Guo-Huan Yang, Qi-Man Sun, Guo-Ming Shi, Jia-Cheng Lu. Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumors. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05670-1
|
16 |
Jian‐Nan Liu, Xiang‐Shuo Kong, Ping Sun, Rui Wang, Wang Li, Qi‐Feng Chen. An integrated pan‐cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity. Journal of Cellular and Molecular Medicine 2021; 25(4): 2082 doi: 10.1111/jcmm.16147
|
17 |
Yutao Yuan, Fangnian Yang, Yuanyuan Wang, Yusong Guo. Factors associated with liver cancer prognosis after hepatectomy. Medicine 2021; 100(42): e27378 doi: 10.1097/MD.0000000000027378
|
18 |
Yichun Wang, Chengjian Ji, Jinhui Liu, Yamin Wang, Ninghong Song, Pu Cao. A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors. International Immunopharmacology 2020; 86: 106710 doi: 10.1016/j.intimp.2020.106710
|